Log Out

US Stock MarketDetailed Quotes

IIIV i3 Verticals

Watchlist

22.927
+0.507+2.26%

Trading Dec 19 11:57 ET

538.96MMarket Cap4.87P/E (TTM)

i3 Verticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

i3 Verticals Q4 2024 Earnings Date

Currency：USDNov 18, 2024

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	61.55M	60.86M	-685.80K
Miss Est.	-36.16%	+3.89%	-1.11%
EPS	0.07	4.65	+4.58
Beat Est.	-38.64%	+4127.27%	+6788.89%

Analyst Rating

Strong Buy

Dec 19, 2024

i3 Verticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

DatePeriodRevenue/EstimateEarnings Call

--2025/Q2-- / 65.065M--

--2025/Q1-- / 59.121M--

Nov 18, 20242024/Q460.864M / 61.550M--

Aug 8, 20242024/Q356.037M / 96.139M--

May 10, 20242024/Q294.542M / 97.466M--

Unlock Free Earnings Estimates

Open Account

i3 Verticals Earnings Reports

i3 Verticals | 10-K: FY2024 Annual Report

Nov 25 16:48 ET

i3 Verticals | 8-K: i3 VERTICALS REPORTS FOURTH QUARTER AND FULL FISCAL YEAR 2024 FINANCIAL RESULTS

Nov 19 06:06 ET

i3 Verticals | 10-Q: Q3 2024 Earnings Report

Aug 9 17:13 ET

i3 Verticals | 8-K: i3 VERTICALS REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS

Aug 8 17:30 ET

Read more

Trending US Stocks

Symbol Mini Chart % Chg

DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS

Halozyme Therapeutics

Collegium Pharmaceutical

Unlock the Full List

Analysis

Analyst Rating

Updated: Dec 19, 2024

Strong Buy

Buy
100.00%
Hold
0.00%
Sell
0.00%

Price Target

No Data